NDC11 57237000205
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57237-0002-05 | 57237-0002 |
| 57237-0002-5 | 57237-0002 |
| 57237-002-05 | 57237-002 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 33f9c3ae-108d-469e-af6c-8be3b0f83139 | 2024-09-13 | Warnings, Adverse reactions | 57237-002-05 57237-002 57237000205 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.